drug
triamcinolone acetonide ER
Marketedupdated 6mo agoby $PCRX Pacira BioSciences, Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugTRIAMCINOLONE ACETONIDE17 co-mentions · 17 sources
- drugKenalog17 co-mentions · 17 sources
- drugtriamcinolone acetonide Rising17 co-mentions · 17 sources
- tagApproval12 co-mentions · 6 sources
- tagRecall11 co-mentions · 11 sources
- drugtestosterone10 co-mentions · 10 sources
- drugTestim10 co-mentions · 10 sources
- drugVogelxo10 co-mentions · 10 sources
all catalysts(0)
nothing on the calendar yet
Trials studying triamcinolone acetonide ER
- phase2A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
- phase3ZILRETTA in Subjects With Shoulder Osteoarthritis
- phase2Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema
- phase4Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
- phase1Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
News(2)
- Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy businessWith an internal non-opioid program nearing approval, Viatris is picking up Pacira BioSciences for a broader pain portfolio and the associated commercial infrastructure.biospace · 1mo ago
- Viatris boosts pain drug portfolio with $1.7B buyout of PaciraThe deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon lose patent protection. Viatris vowed to use its “intellectual property expertise” to su…biopharma_dive · 1mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that